BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 20358157)

  • 1. Iodopovidone pleurodesis: experience of a tertiary hospital in Kolkata.
    Dey A; Bhuniya S; Datta Chaudhuri A; Pandit S; Saha-Dutta Chowdhury M; Sengupta A; Saha I; De P
    Singapore Med J; 2010 Feb; 51(2):163-5. PubMed ID: 20358157
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of iodopovidone pleurodesis through tube thoracostomy.
    Agarwal R; Aggarwal AN; Gupta D
    Respirology; 2006 Jan; 11(1):105-8. PubMed ID: 16423210
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of iodopovidone pleurodesis through chest tube in spontaneous pneumothorax.
    Mahmodlou R; Rahimi-Rad MH; Alizadeh H
    Pneumologia; 2011; 60(2):78-80. PubMed ID: 21823357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A study of comparison of efficacy and safety of talc and povidone iodine for pleurodesis of malignant pleural effusions.
    Das SK; Saha SK; Das A; Halder AK; Banerjee SN; Chakraborty M
    J Indian Med Assoc; 2008 Sep; 106(9):589-90, 592. PubMed ID: 19552086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of iodopovidone pleurodesis and comparison of small-bore catheter versus large-bore chest tube.
    Caglayan B; Torun E; Turan D; Fidan A; Gemici C; Sarac G; Salepci B; Kiral N
    Ann Surg Oncol; 2008 Sep; 15(9):2594-9. PubMed ID: 18594928
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of erythromycin as sclerosing agent in patients with recurrent malignant pleural effusion.
    Balassoulis G; Sichletidis L; Spyratos D; Chloros D; Zarogoulidis K; Kontakiotis T; Bagalas V; Porpodis K; Manika K; Patakas D
    Am J Clin Oncol; 2008 Aug; 31(4):384-9. PubMed ID: 18845999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of iodopovidone pleurodesis in malignant pleural effusions.
    Neto JD; de Oliveira SF; Vianna SP; Terra RM
    Respirology; 2010 Jan; 15(1):115-8. PubMed ID: 19947987
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Local iodine pleurodesis versus thoracoscopic talc insufflation in recurrent malignant pleural effusion: a prospective randomized control trial.
    Mohsen TA; Zeid AA; Meshref M; Tawfeek N; Redmond K; Ananiadou OG; Haj-Yahia S
    Eur J Cardiothorac Surg; 2011 Aug; 40(2):282-6. PubMed ID: 20961772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Iodopovidone and bleomycin pleurodesis for effusions due to malignant epithelial neoplasms.
    Kelly-Garcia J; Roman-Berumen JF; Ibarra-Perez C
    Arch Med Res; 1997; 28(4):583-5. PubMed ID: 9428588
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of iodopovidone versus bleomycin in chemical pleurodesis.
    Bagheri R; Noori M; Rajayi M; Attaran D; Mohammad Hashem Asna Ashari A; Mohammadzadeh Lari S; Basiri R; Rezaeetalab F; Afghani R; Salehi M
    Asian Cardiovasc Thorac Ann; 2018 Jun; 26(5):382-386. PubMed ID: 29792037
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current trends in pleurodesis.
    Rodriguez-Panadero F
    Curr Opin Pulm Med; 1997 Jul; 3(4):319-25. PubMed ID: 9262121
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Povidone-iodine and bleomycin in the management of malignant pleural effusion.
    Alavi AA; Eshraghi M; Rahim MB; Meysami AP; Morteza A; Hajian H
    Acta Med Iran; 2011; 49(9):584-7. PubMed ID: 22052141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pleurodesis with povidone iodine in patients with malignant pleural effusion in a tertiary center in Nigeria.
    Omoregbee BI; Okugbo S
    Pan Afr Med J; 2021; 38():169. PubMed ID: 33995776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pleurodesis.
    Lamb C; Li A; Thakkar D; Lee P
    Semin Respir Crit Care Med; 2019 Jun; 40(3):375-385. PubMed ID: 31525812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Thoracentesis and pleurodesis in the treatment of pleural effusion. Personal experience].
    Pisello F; Geraci G; Sciumè C; Li Volsi F; Platia L; Facella T; Romeo M; Modica G
    G Chir; 2008; 29(6-7):299-304. PubMed ID: 18544270
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Talc pleurodesis in pleuropulmonary diseases treatment.
    Ramić N; Krdžalić G; Mušanović N; Konjić F; Umihanić S; Ramić S; Mustedanagić-Mujanović J; Ljuca F; Zerem E
    Med Glas (Zenica); 2014 Aug; 11(2):264-9. PubMed ID: 25082238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Povidone-iodine pleurodesis versus talc pleurodesis in preventing recurrence of malignant pleural effusion.
    Ibrahim IM; Dokhan AL; El-Sessy AA; Eltaweel MF
    J Cardiothorac Surg; 2015 May; 10():64. PubMed ID: 25947235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Therapeutic pleurodesis in spontaneous pneumothorax, malignant pleural effusion, heart insufficiency and chylothorax].
    Storm HK; Viskum K
    Ugeskr Laeger; 1991 Apr; 153(14):989-92. PubMed ID: 2024319
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Iodopovidone pleurodesis for recurrent pleural effusions.
    Olivares-Torres CA; Laniado-Laborín R; Chávez-García C; León-Gastelum C; Reyes-Escamilla A; Light RW
    Chest; 2002 Aug; 122(2):581-3. PubMed ID: 12171835
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness and safety of iodopovidone in an experimental pleurodesis model.
    Teixeira LR; Vargas FS; Puka J; Acencio MM; Antonangelo L; Terra RM; Damico FM; Pitta FG; Marchi E
    Clinics (Sao Paulo); 2013 Apr; 68(4):557-62. PubMed ID: 23778345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.